UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 131

Sortiert nach

Clinical activity of everolimus in relapsed/refractory marginal zone B‐cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group

British journal of haematology, 2014-07, Vol.166 (1), p.69-76

2014

Link zum Volltext

Verfügbarkeit prüfen

Clinical Features, Management, and Prognosis of an International Series of 161 Patients With Limited‐Stage Diffuse Large B‐Cell Lymphoma of the Bone (the IELSG‐14 Study)

The oncologist (Dayton, Ohio), 2014-03, Vol.19 (3), p.291-298

2014

Link zum Volltext

Verfügbarkeit prüfen

How we diagnose and treat vitreoretinal lymphoma

British journal of haematology, 2016-06, Vol.173 (5), p.680-692

2016

Link zum Volltext

Verfügbarkeit prüfen

How I treat primary CNS lymphoma

Blood, 2011-07, Vol.118 (3), p.510-522

Ferreri, Andrés J.M.

2011

Link zum Volltext

Verfügbarkeit prüfen

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

Haematologica (Roma), 2013-02, Vol.98 (2), p.255-263

2013

Link zum Volltext

Verfügbarkeit prüfen

Chlorambucil versus observation after anti‐Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial

British journal of haematology, 2009-02, Vol.144 (3), p.367-375

2009

Link zum Volltext

Verfügbarkeit prüfen

Chlamydophila psittaci is viable and infectious in the conjunctiva and peripheral blood of patients with ocular adnexal lymphoma: Results of a single‐center prospective case–control study

International journal of cancer, 2008-09, Vol.123 (5), p.1089-1093

2008

Link zum Volltext

Verfügbarkeit prüfen

Chlamydophila Psittaci Eradication With Doxycycline As First-Line Targeted Therapy for Ocular Adnexae Lymphoma: Final Results of an International Phase II Trial

Journal of clinical oncology, 2012-08, Vol.30 (24), p.2988-2994

2012

Link zum Volltext

Verfügbarkeit prüfen

Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients

British journal of haematology, 2002-09, Vol.118 (3), p.817-820

2002

Link zum Volltext

Verfügbarkeit prüfen

Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma

European journal of cancer (1990), 2018-04, Vol.93, p.57-68

2018

Link zum Volltext

Verfügbarkeit prüfen

Bacteria-Eradicating Therapy With Doxycycline in Ocular Adnexal MALT Lymphoma: A Multicenter Prospective Trial

JNCI : Journal of the National Cancer Institute, 2006-10, Vol.98 (19), p.1375-1382

2006

Link zum Volltext

Verfügbarkeit prüfen

Gela histological scoring system for post‐treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practice

British journal of haematology, 2013-01, Vol.160 (1), p.47-52

2013

Link zum Volltext

Verfügbarkeit prüfen

Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma

Blood, 2018-07, Vol.132 (2), p.179-186

2018

Link zum Volltext

Verfügbarkeit prüfen

Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases

British journal of haematology, 2012-10, Vol.159 (2), p.164-171

2012

Link zum Volltext

Verfügbarkeit prüfen

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

Blood, 2013-05, Vol.121 (20), p.4021-4031

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 131

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(123)

Publikationsform

Artikel
(131)

Sprache

Englisch
(131)
Japanisch
(24)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(131)
Life Sciences & Biomedicine
(126)
Science & Technology
(126)
Middle Aged
(119)
Male
(116)
Female
(112)
Adult
(105)
Oncology
(72)
Aged, 80 And Over
(65)
Biological And Medical Sciences
(55)
Medical Sciences
(55)
Hematology
(52)
Treatment Outcome
(52)
Prognosis
(50)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(38)
Hematologic And Hematopoietic Diseases
(38)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(35)
Lymphoma, Large B-Cell, Diffuse - Drug Therapy
(35)
Adolescent
(34)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical activity of everolimus in relapsed/refractory marginal zone B‐cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group

Clinical Features, Management, and Prognosis of an International Series of 161 Patients With Limited‐Stage Diffuse Large B‐Cell Lymphoma of the Bone (the IELSG‐14 Study)

How we diagnose and treat vitreoretinal lymphoma

Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy

How I treat primary CNS lymphoma

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

Chlorambucil versus observation after anti‐Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial

Chlamydophila psittaci is viable and infectious in the conjunctiva and peripheral blood of patients with ocular adnexal lymphoma: Results of a single‐center prospective case–control study

Genomic lesions associated with a different clinical outcome in diffuse large B‐Cell lymphoma treated with R‐CHOP‐21

Chlamydophila Psittaci Eradication With Doxycycline As First-Line Targeted Therapy for Ocular Adnexae Lymphoma: Final Results of an International Phase II Trial

Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma

Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients

Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma

Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions

Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome

Bacteria-Eradicating Therapy With Doxycycline in Ocular Adnexal MALT Lymphoma: A Multicenter Prospective Trial

Gela histological scoring system for post‐treatment biopsies of patients with gastric MALT lymphoma is feasible and reliable in routine practice

Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma

Induction therapy with the MATRix regimen in patients with newly diagnosed primary diffuse large B‐cell lymphoma of the central nervous system – an international study of feasibility and efficacy in routine clinical practice

First-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma With Rituximab-CHOP, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an International Phase II Trial

Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP

Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

Aktive Filter

Suchergebnisse filtern